Serum Lipase and Gallbladder Metastasis in Gastric Cancer
An elevated serum lipase level does not specifically indicate gallbladder metastasis from gastric cancer. [1]
Serum lipase can be elevated from multiple non-pancreatic conditions, including hepatobiliary and gastroduodenal disease, malignancy-related mechanisms, and reduced clearance states. [1]
Interpreting Elevated Serum Lipase
Serum lipase elevation is most commonly associated with acute pancreatitis, but elevated lipase can also occur without pancreatic inflammation. [2]
A systematic review of “significant” hyperlipasemia identified multiple non-pancreatic causes and concluded that non-pancreatic etiologies should be considered when pancreatitis is not supported by clinical or imaging findings. [1]
Non-Pancreatic Sources Relevant to a Gastric Cancer Workup
Non-pancreatic sources of lipase include hepatobiliary and gastroduodenal disease, which can coexist with or mimic malignancy progression in gastrointestinal cancers. [1]
Non-pancreatic malignancy-related causes of hyperlipasemia have been described, including tumor-associated mechanisms. [1]
Gallbladder Metastasis From Gastric Cancer: Diagnostic Implications
Gallbladder metastasis from gastric cancer is documented as a rare occurrence in case reports and small literature sets. [3]
Diagnosis of gallbladder metastasis relies on clinical evaluation plus cross-sectional imaging and tissue confirmation rather than serum lipase elevation alone. [3]
Clinical Approach to Persistent or New Hyperlipasemia
Evaluation for alternative etiologies should be performed when serum lipase is elevated but pancreatitis is not clinically or radiographically evident. [1]
Radiographic assessment of the gallbladder and surrounding hepatobiliary structures should be used to evaluate for metastatic disease when concern for progression exists. [1]
Key Point
Elevated serum lipase in a patient with gastric cancer should not be interpreted as a marker that gallbladder metastasis is present. [1]